(-0.01%) 5 187.21 points
(0.37%) 39 028 points
(-0.17%) 16 304 points
(0.79%) $79.00
(-1.09%) $2.18
(-0.14%) $2 321.00
(0.16%) $27.59
(-0.31%) $985.30
(0.14%) $0.931
(0.09%) $10.91
(0.12%) $0.800
(0.20%) $91.62
Live Chart Being Loaded With Signals
Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology...
Stats | |
---|---|
本日の出来高 | 309 603 |
平均出来高 | 1.49M |
時価総額 | 29.30B |
EPS | INR0 ( 2024-02-13 ) |
次の収益日 | ( INR0 ) 2024-05-20 |
Last Dividend | INR0.500 ( 2021-09-08 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -22.67 |
ATR14 | INR0.106 (0.09%) |
ボリューム 相関
Sequent Scientific 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Sequent Scientific 相関 - 通貨/商品
Sequent Scientific 財務諸表
Annual | 2022 |
収益: | INR14.21B |
総利益: | INR5.87B (41.32 %) |
EPS: | INR-4.88 |
FY | 2022 |
収益: | INR14.21B |
総利益: | INR5.87B (41.32 %) |
EPS: | INR-4.88 |
FY | 2022 |
収益: | INR14.10B |
総利益: | INR5.66B (40.12 %) |
EPS: | INR1.670 |
FY | 2021 |
収益: | INR13.62B |
総利益: | INR6.25B (45.91 %) |
EPS: | INR3.87 |
Financial Reports:
No articles found.
Sequent Scientific Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.200 | 2017-11-20 |
Last Dividend | INR0.500 | 2021-09-08 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | INR0.900 | -- |
Avg. Dividend % Per Year | 0.04% | -- |
Score | 0.38 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 1.078 | |
Div. Directional Score | 0.445 | -- |
Year | Amount | Yield |
---|---|---|
2017 | INR0 | 0.00% |
2018 | INR0 | 0.00% |
2019 | INR0.200 | 0.30% |
2020 | INR0 | 0.00% |
2021 | INR0.500 | 0.29% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SESHAPAPER.NS | Dividend Knight | 2023-06-07 | Annually | 23 | 1.14% | |
MANAKCOAT.NS | Dividend Junior | 2023-08-22 | Sporadic | 4 | 0.09% | |
GOODYEAR.NS | Dividend Knight | 2023-07-26 | Annually | 5 | 4.02% | |
AVANTIFEED.NS | Dividend Junior | 2023-08-03 | Annually | 14 | 0.86% | |
TRIL.NS | Dividend Junior | 2023-07-27 | Sporadic | 17 | 0.22% | |
PILANIINVS.NS | Dividend Junior | 2023-08-29 | Annually | 13 | 0.56% | |
JKCEMENT.NS | Dividend Junior | 2023-08-01 | Annually | 19 | 0.37% | |
DEVIT.NS | Dividend Junior | 2023-09-22 | Annually | 8 | 0.28% | |
SMSPHARMA.NS | Ex Dividend Junior | 2023-09-22 | Annually | 18 | 0.12% | |
MINDTECK.NS | Dividend Junior | 2023-08-04 | Sporadic | 8 | 0.28% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0935 | 1.500 | -1.869 | -2.80 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.186 | 1.500 | -3.18 | -4.77 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -1.024 | 1.000 | -1.490 | -1.490 | [3 - 30] |
operatingCashFlowPerShareTTM | 3.93 | 2.00 | 8.69 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 3.93 | 2.00 | 8.03 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.374 | 1.000 | 7.09 | 7.09 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0346 | 1.000 | -2.69 | -2.69 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -0.187 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -22.92 | 1.000 | -2.42 | 0 | [1 - 100] |
returnOnEquityTTM | -0.186 | 2.50 | -2.04 | -4.77 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 3.93 | 2.00 | 8.69 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 3.93 | 2.00 | 8.69 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.403 | 1.500 | -0.646 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0711 | 1.000 | -0.723 | 0 | [0.1 - 0.5] |
Total Score | 1.078 |
Sequent Scientific
Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。